Cervera, S.T.; Rodríguez-Martín, C.; Fernández-Tabanera, E.; Melero-Fernández de Mera, R.M.; Morin, M.; Fernández-Peñalver, S.; Iranzo-Martínez, M.; Amhih-Cardenas, J.; García-García, L.; González-González, L.;
et al. Therapeutic Potential of EWSR1–FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma. Cancers 2021, 13, 3783.
https://doi.org/10.3390/cancers13153783
AMA Style
Cervera ST, Rodríguez-Martín C, Fernández-Tabanera E, Melero-Fernández de Mera RM, Morin M, Fernández-Peñalver S, Iranzo-Martínez M, Amhih-Cardenas J, García-García L, González-González L,
et al. Therapeutic Potential of EWSR1–FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma. Cancers. 2021; 13(15):3783.
https://doi.org/10.3390/cancers13153783
Chicago/Turabian Style
Cervera, Saint T., Carlos Rodríguez-Martín, Enrique Fernández-Tabanera, Raquel M. Melero-Fernández de Mera, Matias Morin, Sergio Fernández-Peñalver, Maria Iranzo-Martínez, Jorge Amhih-Cardenas, Laura García-García, Laura González-González,
and et al. 2021. "Therapeutic Potential of EWSR1–FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma" Cancers 13, no. 15: 3783.
https://doi.org/10.3390/cancers13153783
APA Style
Cervera, S. T., Rodríguez-Martín, C., Fernández-Tabanera, E., Melero-Fernández de Mera, R. M., Morin, M., Fernández-Peñalver, S., Iranzo-Martínez, M., Amhih-Cardenas, J., García-García, L., González-González, L., Moreno-Pelayo, M. A., & Alonso, J.
(2021). Therapeutic Potential of EWSR1–FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma. Cancers, 13(15), 3783.
https://doi.org/10.3390/cancers13153783
